Cargando…

Mining for novel antibiotics in the age of antimicrobial resistance

The misuse of antimicrobials is causing an alarming increase in the appearance of antibiotic‐resistant microorganisms. In this context, the identification of novel antibiotics against new targets and with low rates of resistance development is a major global challenge. In this article, we highlight...

Descripción completa

Detalles Bibliográficos
Autores principales: Udaondo, Zulema, Matilla, Miguel A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7533334/
https://www.ncbi.nlm.nih.gov/pubmed/32881368
http://dx.doi.org/10.1111/1751-7915.13662
_version_ 1783590110260887552
author Udaondo, Zulema
Matilla, Miguel A.
author_facet Udaondo, Zulema
Matilla, Miguel A.
author_sort Udaondo, Zulema
collection PubMed
description The misuse of antimicrobials is causing an alarming increase in the appearance of antibiotic‐resistant microorganisms. In this context, the identification of novel antibiotics against new targets and with low rates of resistance development is a major global challenge. In this article, we highlight a number of recent articles that exploit a variety of in vitro, in vivo and in silico state‐of‐the‐art approaches to identify and develop new antimicrobials. Rapid progress in this research field will be crucial to combating a global health problem, antimicrobial resistance, that is expected to be the leading cause of death by 2050.
format Online
Article
Text
id pubmed-7533334
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-75333342020-10-07 Mining for novel antibiotics in the age of antimicrobial resistance Udaondo, Zulema Matilla, Miguel A. Microb Biotechnol Highlight The misuse of antimicrobials is causing an alarming increase in the appearance of antibiotic‐resistant microorganisms. In this context, the identification of novel antibiotics against new targets and with low rates of resistance development is a major global challenge. In this article, we highlight a number of recent articles that exploit a variety of in vitro, in vivo and in silico state‐of‐the‐art approaches to identify and develop new antimicrobials. Rapid progress in this research field will be crucial to combating a global health problem, antimicrobial resistance, that is expected to be the leading cause of death by 2050. John Wiley and Sons Inc. 2020-09-02 /pmc/articles/PMC7533334/ /pubmed/32881368 http://dx.doi.org/10.1111/1751-7915.13662 Text en © 2020 The Authors. Microbial Biotechnology published by Society for Applied Microbiology and John Wiley & Sons Ltd This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Highlight
Udaondo, Zulema
Matilla, Miguel A.
Mining for novel antibiotics in the age of antimicrobial resistance
title Mining for novel antibiotics in the age of antimicrobial resistance
title_full Mining for novel antibiotics in the age of antimicrobial resistance
title_fullStr Mining for novel antibiotics in the age of antimicrobial resistance
title_full_unstemmed Mining for novel antibiotics in the age of antimicrobial resistance
title_short Mining for novel antibiotics in the age of antimicrobial resistance
title_sort mining for novel antibiotics in the age of antimicrobial resistance
topic Highlight
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7533334/
https://www.ncbi.nlm.nih.gov/pubmed/32881368
http://dx.doi.org/10.1111/1751-7915.13662
work_keys_str_mv AT udaondozulema miningfornovelantibioticsintheageofantimicrobialresistance
AT matillamiguela miningfornovelantibioticsintheageofantimicrobialresistance